Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

Authors: Conroy, T., Castan, F., Etienne, P.-L., Rio, E., Mesgouez-Nebout, N., Evesque, L., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., Boige, V., Bonichon-Lamichhane, N., Louvet, C., Morand, C., de la Fouchardière, C., Boilève, A., Delaye, M., Gourgou, S., Pezzella, V., Borg, C.

Source: In Annals of Oncology October 2024 35(10):873-881

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Authors: Zawadi, Mohamed-Ayman, Volet, Julien, Cavaglione, Gérard, Lepere, Céline, Rougier, Philippe, Zaanan, Aziz, Besson, Dominique, Fawzi, Kara Slimane, Adenis, Antoine, Gatineau-Sailliant, Gilles, Brezault, Catherine, Coriat, Romain, Tougeron, David, Hautefeuille, Vincent, Chone, Laurence, Molin, Yann, Seitz, Jean-François, Le Tallec, Véronique Jestin, Ben Abdelghani, Meher, Villing, Anne-Laure, Aouakli, Amar, Sebbagh, Virginie, Bedjaoui, Ahmed, Mitry, Emmanuel, Carola, Elisabeth, Boulat, Olivier, Queuniet, Anne-Marie, Capitain, Olivier, Jouve, Jean-Louis, Baumgaertner, Isabelle, Almaric, Françoise, Bonnetain, Franck, Subtil, Fabien, Aparicio, T., Bouché, O., Francois, E., Retornaz, F., Barbier, E., Taieb, J., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Bedenne, L., Paillaud, E.

Source: In European Journal of Cancer July 2018 97:16-24

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Authors: Aparicio, T. ^*, Bouché, O., Taieb, J., Maillard, E., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Paillaud, E., Retornaz, F., François, E., Bedenne, L.

Source: In Annals of Oncology January 2018 29(1):133-138

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

Authors: Bascoul-Mollevi, C., Gourgou, S., Galais, M.-P., Raoul, J.-L., Bouché, O., Douillard, J.-Y., Adenis, A., Etienne, P.-L., Juzyna, B., Bedenne, L., Conroy, T.

Source: In European Journal of Cancer October 2017 84:239-249

A 'giant' pterodactyloid pterosaur from the British Jurassic.

Authors: Etienne, James L., Smith, Roy E., Unwin, David M., Smyth, Robert S.H., Martill, David M.

Source: Proceedings of the Geologists' Association; Jun2024, Vol. 135 Issue 3, p335-348, 14p

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Authors: Aparicio, T., Bouché, O., Francois, E., Retornaz, F., Barbier, E., Taieb, J., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Bedenne, L., Paillaud, E.

Source: European journal of cancer. 97:16-24

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100131604258.0x000001&indx=1&recIds=ETOCvdc_100131604258.0x000001

Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial

Authors: Touchefeu, Y., Guimbaud, R., Louvet, C., Dahan, L., Samalin, E., Barbier, E., Le Malicot, K., Cohen, R., Gornet, J. M., Aparicio, T., Nguyen, S., Azzedine, A., Etienne, P. L., Phelip, J. M., Hammel, P., Chapelle, N., Sefrioui, D., Mineur, L., Lepage, C., Bouche, O.

Source: Gastric cancer. 22(3):577-586

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100126240160.0x000001&indx=1&recIds=ETOCvdc_100126240160.0x000001

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control

Authors: Kotecki, N., Hiret, S., Etienne, P. L., Penel, N., Tresch, E., François, E., Galais, M. P., Ben Abdelghani, M., Michel, P., Dahan, L.

Source: ONCOLOGY -BASEL-. 90(2):88-96

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN375803111&indx=1&recIds=ETOCRN375803111

Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial

Authors: Pénichoux, J., Michiels, S., Bouché, O., Etienne, P.-L., Texereau, P., Auby, D., Rougier, P., Ducreux, M., Pignon, J.-P.

Source: In European Journal of Cancer May 2013 49(8):1882-1888

572P Tolerance of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34 – FFCD 1402 - ADAGE randomized phase III trial

Authors: Aparicio, T., Etienne, P-L., Bouche, O., Barbier, E., Hiret, S., Ammarguellat, H., Desgrippes, R., Martin, J., Meyer, V. Guerin, Le Brun-Ly, V., Ben Abdelghani, M., Falandry, C., Turpin, J., Rinaldi, Y., Desrame, J., Darrius, R., Villing, A-L., Furtos, C.I., Lepage, C., Mineur, L.

Source: In Annals of Oncology September 2024 35 Supplement 2:S465-S466

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy

Authors: Francois, E., Azria, D., Gourgou-Bourgade, S., Jarlier, M., Martel-Laffay, I., Hennequin, C., Etienne, P. L., Vendrely, V., Seitz, J. F., Conroy, T., Juzyna, B., Gerard, J. P.

Source: RADIOTHERAPY AND ONCOLOGY. 110(1):144-149

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN348935803&indx=1&recIds=ETOCRN348935803

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

Authors: Conroy, T., Galais, M. P., Raoul, J. L., Bouché, O., Gourgou-Bourgade, S., Douillard, J. Y., Etienne, P. L., Boige, V. r., Martel-Lafay, I., Michel, P.

Source: LANCET ONCOLOGY. 15(3):305-314

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN348823096&indx=1&recIds=ETOCRN348823096

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial

Authors: Ducreux, M., Malka, D., Mendiboure, J., Etienne, P. L., Texereau, P., Auby, D., Rougier, P., Gasmi, M., Castaing, M., Abbas, M.

Source: LANCET ONCOLOGY. 12(11):1032-1044

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN299226047&indx=1&recIds=ETOCRN299226047

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

Authors: Conroy, T., Yatagh&ene, Y., Etienne, P. L., Michel, P., Senellart, H., Raoul, J. L., Mineur, L., Rives, M., Mirabel, X., Lamezec, B.

Source: BRITISH JOURNAL OF CANCER. 103(9):1349-1355

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN280232852&indx=1&recIds=ETOCRN280232852

Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710

Authors: Dahan, L., Bonnetain, F., Rougier, P., Raoul, J.-L., Gamelin, E., Etienne, P.-L., Cadiot, G., Mitry, E., Smith, D., Cvitkovic, F.

Source: ENDOCRINE RELATED CANCER. 16(4):1351-1361

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN261972734&indx=1&recIds=ETOCRN261972734

LBA-04 The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results

Authors: Bennouna, J., Etienne, P.-L., Bogart, E., Galais, M.-P., Benabdelghani, M., Francois, E., Michel, P., Dahan, L., Metges, J.-P., Ghiringhelli, F., Conroy, T., Kotecki, N., Bedenne, L., El Hajbi, F., Samalin, E., Piessen, G., Delaine-Clisant, S., Penel, N., Mariette, C., Adenis, A.

Source: In Annals of Oncology June 2016 27 Supplement 2:ii141-ii141

Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma. Results of a phase II trial

Authors: Mitry, E., Ducreux, M., Ould-Kaci, M., Boige, V., Seitz, J. F., Bugat, R., Breau, J. L., Bouche, O., Etienne, P. L., Tigaud, J. M.

Source: GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. 30(3):357-363

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN186421230&indx=1&recIds=ETOCRN186421230

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer-A GERCOR Study

Authors: Tournigand, C., Cervantes, A., Figer, A., Lledo, G., Flesch, M., Buyse, M., Mineur, L., Carola, E., Etienne, P.-L., Rivera, F.

Source: JOURNAL OF CLINICAL ONCOLOGY. 24(3):394-400

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN181327144&indx=1&recIds=ETOCRN181327144

Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology

Authors: Bonnetain, F., Bouche, O., Conroy, T., Arveux, P., Raoul, J.-L., Giovannini, M., Etienne, P. L., Mitry, E., Seitz, J.-F., Rougier, P.

Source: GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. 29(11):1113-1124

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN179047959&indx=1&recIds=ETOCRN179047959

Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Federation Francophone de Cancerologie Digestive Group Study-FFDC 9803

Authors: Bouche, O., Raoul, J. L., Bonnetain, F., Giovannini, M., Etienne, P. L., Lledo, G., Arsene, D., Paitel, J. F., Guerin-Meyer, V., Mitry, E.

Source: JOURNAL OF CLINICAL ONCOLOGY. 22(21):4319-4328

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN158419383&indx=1&recIds=ETOCRN158419383